Clinical Trial Update: Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing the combined Rosuvastatin/Ezetimibe with Telmisartan for hypercholesterolemia and hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hypertension

Drugs mentioned

• Rosuvastatin/Ezetimibe (rosuvastatin; ezetimibe)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Addpharma Inc. | Conditions: Hypercholesterolemia, Hypertension | Phase 3 | Status: COMPLETED